A pharmaceutical company has selected SJP Properties to manage the build-out of its new 300,000-square-foot U.S. headquarters in Nutley.
Prism Capital Partners has sold a 157,000-square-foot life sciences building at its ON3 campus, in a sign of investor appetite for modern lab and research and development space.
Office leasing in New Jersey rebounded modestly in the third quarter, even as the pandemic continues to weigh on the market and fuels a sizable uptick in availabilities.
The developer of a 108-unit apartment building in Nutley has sold the property for $19 million, in a newly announced transaction by Gebroe-Hammer Associates.
Tulfra Real Estate has reaped more than $24 million from the sale of a newly developed, 925-unit self-storage facility in northern New Jersey.
A global pharmaceutical company is moving its U.S. headquarters to Prism Capital Partners’ ON3 campus, having signed a full-building lease for the site’s landmark 15-story office tower.
After decades of consolidation by Big Pharma, demand for modern lab and diagnostic space in New Jersey is on the rise, fueling rent growth and pushing some developers to consider new laboratory projects.
Prism Capital Partners is doing its part to help the health care community in the fight against COVID-19, having donated a trove of critical safety gear found at its flagship ON3 campus.
The nation’s life sciences sector continues to expand, boosted by technological advancements, growing employment and a strong economy. While Boston and San Francisco remain the country’s main life sciences hub, their tightening inventory and constrained labor force has driven momentum south to the Garden State.